Navigation Links
Vanda Pharmaceuticals Reports Fourth Quarter 2011 and Full Year 2011 Results
Date:2/14/2012

y the end of 2012.

The tasimelteon MAGELLAN efficacy study for MDD is ongoing and Vanda expects to report top-line results in the first half of 2013. This Phase IIb/III study in MDD was initiated in September 2011 and is expected to enroll 500 patients across approximately 40 sites.

Full year 2011 Fanapt® prescriptions, as reported by IMS, exceeded 120,000 compared to approximately 55,000 for 2010.  Vanda has been informed that Novartis is continuing the Phase II development program for the long-acting injectable formulation of Fanapt®.

The review of Vanda's Marketing Authorization Application (MAA) for oral iloperidone tablets in the European Union is ongoing.  The European Medicines Agency (EMA) has provided its standard 120-day list of questions and has granted Vanda a 3-month extension, through mid-May 2012, for Vanda to prepare its response.  After further evaluation of the regulatory and commercial environment, Vanda has no current plans to pursue registration for Fanapt® in Singapore and Australia.  Regulatory filings for market approval of Fanapt® by Vanda's commercial partners are under review in Israel, Mexico and Argentina.  

CONFERENCE CALLVanda has scheduled a conference call for today, Tuesday, February 14, 2012, at 10:00 AM ET.  During the call, Vanda's management will discuss the fourth quarter and full year 2011 results and other corporate activities.  Investors can call 866-271-0675 (domestic) and 617-213-8892 (international) and use passcode 76685033.  A replay of the call will be available beginning Tuesday, February 14, 2012 at 12:00 PM ET and will be accessible until Tuesday, February 21, 2012, at 5:00 PM ET.  The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers.  The access number is 37381299.

The conference call will be broadcast simultaneously on Vanda's website,

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
2. Vanda Pharmaceuticals Reports Third Quarter 2007 Results
3. Vanda Pharmaceuticals Receives FDA Acceptance of Iloperidone New Drug Application
4. Vanda Presents Phase III Iloperidone Efficacy Data
5. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
6. Vanda Pharmaceuticals Provides Update on Iloperidone
7. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
8. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
11. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive Intelligence ... and marketplace changes. CI leaders who adjust will succeed, ... In a new Best Practices, LLC study CI leaders ... insights, including: - Use secondary research whenever ... research - Internal staff who are creative ...
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2
... N.J., July 15, 2011 Crestor and ... to lower "bad cholesterol". Both drugs are classified as ... HMG-CoA reductase. This group of drugs has had a ... Crestor and Zocor, touted as a "super statin" before ...
... -- CoLucid Pharmaceuticals, Inc., a privately held biopharmaceutical company, ... as Chief Executive Officer. Mr. Mathers has ... marketing experience in the life sciences and medical device ... for the Biotechnology Industry Organization (BIO), and as chairman ...
Cached Medicine Technology:Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis 2CoLucid Appoints Thomas P. Mathers as Chief Executive Officer 2
(Date:8/30/2014)... Recently, Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... BlueHost and JustHost ( http://www.justhost.com/track/seohosts ) are great ... high quality web hosting. , “The hosting ... companies who outperform their competitors on hosting features, ... spokesman for Top 10 Best SEO Hosting says, ...
(Date:8/30/2014)... 2014 Recently, iFitDress.com, one of the ... designs of classy bridesmaid dresses . For additional ... 22 percent off to 62 percent off) for all ... items. , True enough, iFitDress.com is an industry ... gowns. The company persists in making trendy products that ...
(Date:8/30/2014)... August 31, 2014 Fast hosting ... websites. Top10BestSEOHosting.com has recently compared many professional web ... http://www.hostmonster.com/track/seohosts ) and Arvixe are the suppliers of ... hard to find a good fast hosting supplier. ... hosting features, uptime, server speed and customer support. ...
(Date:8/30/2014)... 31, 2014 Recently, Skmen.com, a well-known ... long casual dresses . Before the middle of September, ... a discounted price, from 15 to 30 percent off. ... company’s long casual outfits are carefully made and come ... look for the wearers. Skmen.com is popular for its ...
(Date:8/30/2014)... Information supplied by insurance companies has been helping ... consumers in 2014. A group of ratess for term ... open system for adults at http://quotespros.com/life-insurance.html . ... year can help the average person to quote a ... from medical histories. The finder tool works under a ...
Breaking Medicine News(10 mins):Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... 27, 2008 Overweight Hispanic children with normal blood glucose ... may predispose them to developing both type 2 diabetes and ... the Joslin Diabetes Center. , The study, published in the ... on Hispanic children, already known to be at high risk ...
... the United States government should convert the Guantanamo ... research institute dedicated to combating diseases of poverty. ... Neglected Tropical Diseases, Editor-in-Chief Peter Hotez says that ... position to directly address the poverty-promoting diseases and ...
... Disputes, SPOKANE, Wash., Feb. 26 Recently, ... settlement on four,outstanding disputes. The approximately 110 nurses ... "This settlement is very important for the nurses, ... refusal to negotiate a fair,contract," said Buck Holliday, ...
... 26 Local communities,can be effective in preventing ... and heart disease if they use healthy eating ... principles identified by,leading national programs., Communities are ... nation. There are eight leading national programs which ...
... (Nasdaq: IDIX ) announced today that Idenix management,will ... in Healthcare Conference hosted by Susquehanna Financial Group on,Wednesday, ... W Hotel in the Sea/Ocean,Room in New York, NY., ... the company presentation,can be accessed under "Calendar of Events" ...
... Additional Benefit Found for Personalized Intervention to Promote ... interventions did not significantly increase regular mammography screening ... such as personalized mailings, have been reported to ... examined the impact of behavioral interventions on regular ...
Cached Medicine News:Health News:Overweight Hispanic children shown to have vascular inflammation 2Health News:From detainee facility to health advocacy center: A new role for Guantanamo? 2Health News:Nurses Convince Hospital to Return to Bargaining Table 2Health News:Effective Healthy Eating and Physical Activity Initiatives Can Reduce Health Disparities 2Health News:Other highlights in the Feb. 26 JNCI 2Health News:Other highlights in the Feb. 26 JNCI 3Health News:Other highlights in the Feb. 26 JNCI 4
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
... bags are part of the Freedom ... of leg bags, kits, and accessories ... of our customers. These leg bags ... constructed of 100% latex-free soft, textured ...
... part of the Freedom Urinary Collection ... bags, kits, and accessories designed to ... customers. These leg bags are offered ... 100% latex-free soft, textured medical grade ...
Medicine Products: